AbbVie is buying a biotech company working on an experimental eczema drug for $10.9 billion
Apogee Therapeutics is developing a promising atopic dermatitis drug.
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
3153 articles about stocks
Apogee Therapeutics is developing a promising atopic dermatitis drug.
The mixed messages on AI are another challenge when Gen Z already faces a tough job market.
TORONTO, ON / ACCESS Newswire / June 22, 2026 /Adcore Inc. (TSX:ADCO)(OTCQX:ADCOF)(FSE:ADQ) ("Adcore" or the "Company"), a global leader in AI marketing te...
Why is Ligand Pharmaceuticals stock sliding today?
ITG targets $2.67 billion valuation in U.S. IPO
Prior records for U.S. equity issuance came in 1929 and 2000 - and we all know what happened next.
Why is Credo Technology stock surging today?
BofA Picks Top European Industrial Stocks Amid Cyclical Pressures
Your look at what's coming in the week starting June 22.
South KoreaâEUR(TM)s FIU is calling for broader crypto transfer reporting rules during FATF talks, citing offshore risks and uneven global AML enforcement.
European shares muted as investors weigh U.S.-Iran talks
Why is OHB stock down today?